Ticker > Company >

Cell Point (India) share price

Cell Point (India) Ltd.

NSE: CELLPOINT SECTOR: Trading  15.25 K   5   0

18.15
+0.40 (2.25%)
NSE: Today, 03:42 PM

Price Summary

Today's High

₹ 18.15

Today's Low

₹ 18.1

52 Week High

₹ 31.5

52 Week Low

₹ 15.6

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

33.91 Cr.

Enterprise Value

72.73 Cr.

No. of Shares

1.87 Cr.

P/E

15

P/B

0.46

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  39.74

CASH

6.44 Cr.

DEBT

45.25 Cr.

Promoter Holding

73.06 %

EPS (TTM)

₹  1.21

Sales Growth

1.08%

ROE

3.09 %

ROCE

6.65%

Profit Growth

33.56 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year1.08%
3 Year6.45%
5 Year3.19%

Profit Growth

1 Year33.56%
3 Year11.16%
5 Year7.17%

ROE%

1 Year3.09%
3 Year15.66%
5 Year13.24%

ROCE %

1 Year6.65%
3 Year13.77%
5 Year15.07%

Debt/Equity

0.6095

Price to Cash Flow

-49.26

Interest Cover Ratio

1.5436

CFO/PAT (5 Yr. Avg.)

0.0837187149507582

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2025 73.06 0.00
Jun 2025 73.06 0.00
Mar 2025 73.06 0.00
Dec 2024 73.06 0.00
Sep 2024 73.06 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.446880504729917.
  • The company has an efficient Cash Conversion Cycle of 51.9362 days.
  • The company has a high promoter holding of 73.06%.

 Limitations

  • The company has shown a poor revenue growth of 6.45287868618161% for the Past 3 years.
  • Company has negative cash flow from operations of -0.6885.
  • The company has a low EBITDA margin of 3.70872765599413% over the past 5 years.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 223.01 269.16 295.67 321.23 324.71
Total Expenditure 215.22 258.37 277.66 312.58 317.39
Operating Profit 7.79 10.79 18.01 8.65 7.32
Other Income 0.55 0.88 1.33 1.67 1.55
Interest 5.86 8.12 8.53 5.74 5.18
Depreciation 1.2 1.12 0.95 1.86 3.23
Exceptional Items 0 0 0 0 2.35
Profit Before Tax 1.27 2.43 9.87 2.72 2.81
Tax 0.58 0.78 3.14 1.03 0.55
Net Profit 0.69 1.65 6.73 1.69 2.26
Adjusted EPS (Rs.) 5.57 13.27 4.93 0.91 1.21

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 1.14 1.14 13.65 18.69 18.69
Total Reserves 10.58 12.22 6.43 53.43 55.57
Borrowings 23.66 19.81 18.06 1.11 0.9
Other N/C liabilities -0.72 -0.72 -0.54 -0.52 0.13
Current liabilities 29.58 50.15 56.29 60.94 62.4
Total Liabilities 64.24 82.6 93.9 133.66 137.69
Assets
Net Block 19.33 18.67 18.17 33.22 36.54
Capital WIP 0 0 0 0 0.79
Intangible WIP 0 0 0 0 0
Investments 0 0.02 0.18 0.09 0.8
Loans & Advances 12.98 13.09 14.99 28.72 20.68
Other N/C Assets 0.11 0 0 0 0
Current Assets 31.81 50.82 60.56 71.63 78.88
Total Assets 64.24 82.6 93.9 133.66 137.69
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 1.27 2.43 9.87 2.72 2.81
Adjustment 3.56 8.88 9.23 5.85 4.56
Changes in Assets & Liabilities -1.8 -10.73 -10.78 -13.97 -8.06
Tax Paid -0.68 -0.93 -1.35 -1.78 -0.01
Operating Cash Flow 2.35 -0.35 6.96 -7.18 -0.69
Investing Cash Flow -1.35 -0.46 -0.45 -30.55 2.34
Financing Cash Flow -0.35 5.47 -4.1 39.25 -7.21
Net Cash Flow 0.65 4.66 2.42 1.52 -5.56

Corporate Actions

Investors Details

PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
promoters 73.06 73.06 73.06 73.06 73.06
bala balaji panday 8.51 8.51 8.51 8.51 8.51
mohan prasad panday 64.54 64.54 64.54 64.54 64.54
nagendra prasad pande 0.01 0.01 0.01 - 0.01
nagendra pradad pande - - - 0.01 -
 No Investors Data available for this company.Report us

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2024

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Cell Point (India) Stock Price Analysis and Quick Research Report. Is Cell Point (India) an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Cell Point (India). 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Cell Point (India) has a PE ratio of 14.9962819135751 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Cell Point (India) has ROA of 1.6669% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Cell Point (India) has a Current ratio of 1.264.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Cell Point (India) has a ROE of 3.0901%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Cell Point (India) has a Debt to Equity ratio of 0.6095 which means that the company has low proportion of debt in its capital.

  • Sales growth: Cell Point (India) has reported revenue growth of 1.0809% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Cell Point (India) for the current financial year is 2.25397813837076%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Cell Point (India) is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Cell Point (India) is Rs 1.2103. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Cell Point (India) in Ticker for free. Also, one can get the intrinsic value of Cell Point (India) by using Valuation Calculators, which are available with a Finology ONE subscription. 

Cell Point (India) FAQs

Q1. What is Cell Point (India) share price today?
Ans: The current share price of Cell Point (India) is Rs 18.15.

Q2. What is the market capitalisation of Cell Point (India)?
Ans: Cell Point (India) has a market capitalisation of Rs 33.914364 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Cell Point (India)?
Ans: The PE ratio of Cell Point (India) is 14.9962819135751 and the P/B ratio of Cell Point (India) is 0.456734761667497, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Cell Point (India) share?
Ans: The 52-week high share price of Cell Point (India) is Rs 31.5, and the 52-week low share price of Cell Point (India) is Rs 15.6.

Q5. Does Cell Point (India) pay dividends?
Ans: Currently, Cell Point (India) does not pay dividends. Dividend yield of Cell Point (India) is around 0%.

Q6. What are the face value and book value of Cell Point (India) shares?
Ans: The face value of Cell Point (India) shares is Rs 10, while the book value per share of Cell Point (India) is around Rs 39.7386. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Cell Point (India)?
Ans: Cell Point (India) has a total debt of Rs 45.2544 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Cell Point (India)?
Ans: The ROE of Cell Point (India) is 3.0901% and ROCE of Cell Point (India) is 6.6477%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Cell Point (India) a good buy for the long term?
Ans: The Cell Point (India) long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Cell Point (India) undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Cell Point (India) appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Cell Point (India)’s financials?
Ans: You can review Cell Point (India)’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Cell Point (India)
X